FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040336522> ?p ?o ?g. }

• W2040336522 endingPage "106" @default.
• W2040336522 startingPage "101" @default.
• W2040336522 abstract "Observational study data have suggested that neurologists preferentially selected younger patients with generally few traditional stroke risk factors for homocysteine testing. The aim of this study was to corroborate observational data by assessing neurologists’ reported practices for the detection and treatment of hyperhomocysteinemia in patients with acute ischemic stroke. All academic neurology faculty (n = 49), trainees (neurology residents/fellows, n = 53), and a random sample of community-based neurologists (n = 66) throughout North Carolina were surveyed regarding their homocysteine testing and treatment practices. Nine neurologists were ineligible because they had either retired or moved out of state. A total of 93 of the remaining 159 surveys (58.5%) were completed (response rates: faculty, 74%; trainees, 47%; community-based neurologists, 56%). Patients age < 50 years (n = 52; 63%) and the absence of traditional stroke risk factors (n = 57; 70%) were the most common factors cited as prompting homocysteine testing. The homocysteine level threshold for treatment varied independently by practice type (faculty: median, 14 μmol/L; range, 6–16 μmol/L; trainees: median, 14.5 μmol/L; range, 10–20 μmol/L; community-based: median, 10.4 μmol/L; range, 7–15 μmol/L; P = .01), the number of stroke patients evaluated during a typical week (Spearman’s r = .32; P = .034), and year of training completion (Spearman’s r = .41; P = .003). About half (51%) treat elevated homocysteine with a combination of folate, vitamin B12, and vitamin B6. Consistent with observational data, the majority of the neurologists surveyed report that they select young stroke patients who lack traditional stroke risk factors for homocysteine testing. Thresholds for treatment varied between community-based and academic neurologists and correlated with the physicians’ stroke patient volume. Observational study data have suggested that neurologists preferentially selected younger patients with generally few traditional stroke risk factors for homocysteine testing. The aim of this study was to corroborate observational data by assessing neurologists’ reported practices for the detection and treatment of hyperhomocysteinemia in patients with acute ischemic stroke. All academic neurology faculty (n = 49), trainees (neurology residents/fellows, n = 53), and a random sample of community-based neurologists (n = 66) throughout North Carolina were surveyed regarding their homocysteine testing and treatment practices. Nine neurologists were ineligible because they had either retired or moved out of state. A total of 93 of the remaining 159 surveys (58.5%) were completed (response rates: faculty, 74%; trainees, 47%; community-based neurologists, 56%). Patients age < 50 years (n = 52; 63%) and the absence of traditional stroke risk factors (n = 57; 70%) were the most common factors cited as prompting homocysteine testing. The homocysteine level threshold for treatment varied independently by practice type (faculty: median, 14 μmol/L; range, 6–16 μmol/L; trainees: median, 14.5 μmol/L; range, 10–20 μmol/L; community-based: median, 10.4 μmol/L; range, 7–15 μmol/L; P = .01), the number of stroke patients evaluated during a typical week (Spearman’s r = .32; P = .034), and year of training completion (Spearman’s r = .41; P = .003). About half (51%) treat elevated homocysteine with a combination of folate, vitamin B12, and vitamin B6. Consistent with observational data, the majority of the neurologists surveyed report that they select young stroke patients who lack traditional stroke risk factors for homocysteine testing. Thresholds for treatment varied between community-based and academic neurologists and correlated with the physicians’ stroke patient volume." @default.
• W2040336522 created "2016-06-24" @default.
• W2040336522 creator A5067115440 @default.
• W2040336522 creator A5070426067 @default.
• W2040336522 date "2005-05-01" @default.
• W2040336522 modified "2023-09-27" @default.
• W2040336522 title "Neurologists’ Evaluation and Treatment of Hyperhomocysteinemia in Stroke Patients" @default.
• W2040336522 cites W1601668898 @default.
• W2040336522 cites W1883798927 @default.
• W2040336522 cites W1973553845 @default.
• W2040336522 cites W1976556685 @default.
• W2040336522 cites W1986418570 @default.
• W2040336522 cites W1995331933 @default.
• W2040336522 cites W1996233154 @default.
• W2040336522 cites W2006178210 @default.
• W2040336522 cites W2045649046 @default.
• W2040336522 cites W2050878161 @default.
• W2040336522 cites W2053924451 @default.
• W2040336522 cites W2058737278 @default.
• W2040336522 cites W2087461651 @default.
• W2040336522 cites W2088607865 @default.
• W2040336522 cites W2091329460 @default.
• W2040336522 cites W2094548662 @default.
• W2040336522 cites W2117836631 @default.
• W2040336522 cites W2124407220 @default.
• W2040336522 cites W2124670884 @default.
• W2040336522 cites W2125756592 @default.
• W2040336522 cites W2152148859 @default.
• W2040336522 cites W2165529627 @default.
• W2040336522 cites W2337184574 @default.
• W2040336522 cites W2528224072 @default.
• W2040336522 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2005.01.003" @default.
• W2040336522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17904008" @default.
• W2040336522 hasPublicationYear "2005" @default.
• W2040336522 type Work @default.
• W2040336522 sameAs 2040336522 @default.
• W2040336522 citedByCount "1" @default.
• W2040336522 crossrefType "journal-article" @default.
• W2040336522 hasAuthorship W2040336522A5067115440 @default.
• W2040336522 hasAuthorship W2040336522A5070426067 @default.
• W2040336522 hasConcept C118552586 @default.
• W2040336522 hasConcept C126322002 @default.
• W2040336522 hasConcept C127413603 @default.
• W2040336522 hasConcept C16568411 @default.
• W2040336522 hasConcept C1862650 @default.
• W2040336522 hasConcept C187212893 @default.
• W2040336522 hasConcept C23131810 @default.
• W2040336522 hasConcept C2776523773 @default.
• W2040336522 hasConcept C2777090595 @default.
• W2040336522 hasConcept C2780645631 @default.
• W2040336522 hasConcept C71924100 @default.
• W2040336522 hasConcept C78519656 @default.
• W2040336522 hasConceptScore W2040336522C118552586 @default.
• W2040336522 hasConceptScore W2040336522C126322002 @default.
• W2040336522 hasConceptScore W2040336522C127413603 @default.
• W2040336522 hasConceptScore W2040336522C16568411 @default.
• W2040336522 hasConceptScore W2040336522C1862650 @default.
• W2040336522 hasConceptScore W2040336522C187212893 @default.
• W2040336522 hasConceptScore W2040336522C23131810 @default.
• W2040336522 hasConceptScore W2040336522C2776523773 @default.
• W2040336522 hasConceptScore W2040336522C2777090595 @default.
• W2040336522 hasConceptScore W2040336522C2780645631 @default.
• W2040336522 hasConceptScore W2040336522C71924100 @default.
• W2040336522 hasConceptScore W2040336522C78519656 @default.
• W2040336522 hasIssue "3" @default.
• W2040336522 hasLocation W20403365221 @default.
• W2040336522 hasLocation W20403365222 @default.
• W2040336522 hasOpenAccess W2040336522 @default.
• W2040336522 hasPrimaryLocation W20403365221 @default.
• W2040336522 hasRelatedWork W1969118882 @default.
• W2040336522 hasRelatedWork W1977240908 @default.
• W2040336522 hasRelatedWork W1997237209 @default.
• W2040336522 hasRelatedWork W2040336522 @default.
• W2040336522 hasRelatedWork W2051592475 @default.
• W2040336522 hasRelatedWork W2072921720 @default.
• W2040336522 hasRelatedWork W2247269146 @default.
• W2040336522 hasRelatedWork W2389000723 @default.
• W2040336522 hasRelatedWork W2758750505 @default.
• W2040336522 hasRelatedWork W2902687972 @default.
• W2040336522 hasVolume "14" @default.
• W2040336522 isParatext "false" @default.
• W2040336522 isRetracted "false" @default.
• W2040336522 magId "2040336522" @default.
• W2040336522 workType "article" @default.